ICM
GEHC icon

Invenomic Capital Management’s GE HealthCare GEHC Stock Holding History

Invenomic Capital Management’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9M Buy
+233,035
New +$15.3M 0.89% 44
2025
Q3 		– Sell
-96,697
Closed -$7.16M – 156
2025
Q2 		$7.16M Buy
+96,697
New +$6.73M 0.41% 77

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invenomic Capital Management's GEHC Position: Q2 2026 in Review

Invenomic Capital Management opened a new position in GE HealthCare (GEHC) in Q2 2026: 233,035 shares worth $14.9M. The stake represents 0.89% of the portfolio and ranks #44 among its holdings. This is a return to the name: Invenomic Capital Management previously reported a position in GEHC as recently as Q2 2025.

Invenomic Capital Management first reported a position in GEHC in Q2 2025 and has held it in 2 quarters since. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Invenomic Capital Management held 233,035 shares of GE HealthCare worth $14.9M as of Q2 2026.
  • GE HealthCare was a new Invenomic Capital Management position in Q2 2026.
  • GE HealthCare made up 0.89% of Invenomic Capital Management's portfolio in Q2 2026, its #44 holding.
  • Invenomic Capital Management first reported a position in GE HealthCare in Q2 2025 and has held it in 2 quarters since.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.